Kestra Private Wealth Services, LLC Repligen Corp Transaction History

Kestra Private Wealth Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 26, 2022	SELL	$161.19 - $257.96 $262,900 - $420,732	-1,631 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$247.59 - $304.47 $25,996 - $31,969	-105 Reduced 6.05%	1,631 $431,000
Q3 2021 Oct 21, 2021	BUY	$194.77 - $324.21 $338,120 - $562,828	1,736 New	1,736 $501,000
Q2 2021 Jul 30, 2021	SELL	$165.87 - $220.95 $287,950 - $383,569	-1,736 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$180.37 - $226.26 $313,122 - $392,787	1,736 New	1,736 $337,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.